Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

NCT02638857 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Recurrence Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma

Interventions

PROCEDURE: TACE
BIOLOGICAL: Dendritic Cell
DRUG: lipiodol
DRUG: Mitomycin (MMC)
DRUG: Epirubicin(EADM)
BIOLOGICAL: Precision Multiple Antigen T Cell

Sponsor

Second Military Medical University